Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Pediatrix Medical (MD) over the last 12 years, with Q4 2024 value amounting to $987593.0.

  • Pediatrix Medical's Gains from Sales and Divestitures rose 13583.97% to $987593.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $987593.0, marking a year-over-year increase of 13583.97%. This contributed to the annual value of $987593.0 for FY2024, which is 13583.97% up from last year.
  • Pediatrix Medical's Gains from Sales and Divestitures amounted to $987593.0 in Q4 2024, which was up 13583.97% from $418756.0 recorded in Q4 2023.
  • In the past 5 years, Pediatrix Medical's Gains from Sales and Divestitures registered a high of $987593.0 during Q4 2024, and its lowest value of $418756.0 during Q4 2023.
  • For the 4-year period, Pediatrix Medical's Gains from Sales and Divestitures averaged around $721202.2, with its median value being $739230.0 (2021).
  • As far as peak fluctuations go, Pediatrix Medical's Gains from Sales and Divestitures crashed by 4264.01% in 2023, and later soared by 13583.97% in 2024.
  • Over the past 4 years, Pediatrix Medical's Gains from Sales and Divestitures (Quarter) stood at $748410.0 in 2021, then dropped by 2.45% to $730050.0 in 2022, then plummeted by 42.64% to $418756.0 in 2023, then surged by 135.84% to $987593.0 in 2024.
  • Its last three reported values are $987593.0 in Q4 2024, $418756.0 for Q4 2023, and $730050.0 during Q4 2022.